Cite

HARVARD Citation

    Pilely, K. et al. (2019). Alpha-cyclodextrin inhibits cholesterol crystal-induced complement-mediated inflammation: A potential new compound for treatment of atherosclerosis. Atherosclerosis. pp. 35-42. [Online]. 
  
Back to record